Patents by Inventor Winston E. Gutteridge

Winston E. Gutteridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatng protozoal infections caused by microsporidia
    Patent number: 5561164
    Abstract: The present invention relates to pharmaceutical compositions for the treatment of infections caused by Microsporidia comprising treating an animal with 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone or a physiologically acceptable salt thereof.
    Type: Grant
    Filed: June 9, 1995
    Date of Patent: October 1, 1996
    Assignee: Glaxo Wellcome Inc.
    Inventors: Winston E. Gutteridge, Alan T. Hudson, Victoria S. Latter, Mary Pudney
  • Method for treating animals infected with Babesia spp.
    Patent number: 5559156
    Abstract: The present invention relates to pharmaceutical compositions for the treatment and/or prophylaxis of protozoal infections caused by Kinetoplastida, Apicomplexa, Anaerobic protozoa and Mircosporidia comprising 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone or a physiologically acceptable salt or other functional derivative thereof as active ingredient and to a method of treating or preventing siad protozoal infections in an animal which comprises administering to said animal an effective amount of siad compound.
    Type: Grant
    Filed: November 8, 1994
    Date of Patent: September 24, 1996
    Assignee: Glaxo Wellcome, Inc.
    Inventors: Winston E. Gutteridge, Alan T. Hudson, Victoria S. Latter, Mary Pudney
  • Medicaments
    Patent number: 5466711
    Abstract: A method for treating or preventing a Pneumocystis carinii infection in a mammal by administering a certain naphthoquinone compound or physiologically acceptable salts thereof.
    Type: Grant
    Filed: May 20, 1992
    Date of Patent: November 14, 1995
    Assignee: Burroughs Wellcome Co.
    Inventors: Victoria S. Latter, Winston E. Gutteridge, Alan T. Hudson
  • Medicaments
    Patent number: 5310762
    Abstract: A method for treating or preventing a Pneumocystis carinii infection in a mammal by administering a certain naphthoquinone compound or physiologically acceptable salts thereof.
    Type: Grant
    Filed: November 22, 1991
    Date of Patent: May 10, 1994
    Assignee: Burroughs Wellcome Co.
    Inventors: Victoria S. Latter, Winston E. Gutteridge, Alan T. Hudson
  • Medicaments
    Patent number: 5225184
    Abstract: The present invention relates to the treatment and prophylaxis of Pneumocystis carinii infections with 2-[4-(4-chlorophenyl)cyclohexyl-3-hydroxy-1,4-naphthoquinone.
    Type: Grant
    Filed: November 29, 1990
    Date of Patent: July 6, 1993
    Assignee: Burroughs Wellcome Co.
    Inventors: Victoria S. Latter, Winston E. Gutteridge
  • Medicaments
    Patent number: 5206268
    Abstract: A method for treating or preventing a Pneumocystis carinii infection in a mammal by administering a certain naphthoquinone compound or physiologically acceptable salts thereof.
    Type: Grant
    Filed: August 15, 1989
    Date of Patent: April 27, 1993
    Assignee: Burroughs Wellcome Co.
    Inventors: Victoria S. Latter, Winston E. Gutteridge, Alan T. Hudson
  • Medicaments
    Patent number: 4981874
    Abstract: A method and certain compositions for treating Pneumocystis carinii infections in a mammal by administering a certain naphthoquinone compound or physiologically acceptable salts thereof.
    Type: Grant
    Filed: August 15, 1989
    Date of Patent: January 1, 1991
    Inventors: Victoria S. Latter, Winston E. Gutteridge